HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea Labelle Selected Research

Hemostatics (Antihemorrhagics)

1/2008Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea Labelle Research Topics

Disease

6Hemophilia A (Haemophilia)
04/2011 - 07/2006
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
10/2007
1Thrombocytopenia (Thrombopenia)
04/2007

Drug/Important Bio-Agent (IBA)

4Factor VIII (Coagulation Factor VIII)IBA
04/2011 - 07/2006
1AntibodiesIBA
04/2011
1MicroRNAs (MicroRNA)IBA
04/2011
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
04/2011
1Interferon-gamma (Interferon, gamma)IBA
07/2009
1Interleukin-6 (Interleukin 6)IBA
07/2009
1Interleukin-10 (Interleukin 10)IBA
07/2009
1CytokinesIBA
01/2009
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
01/2008
1Pharmaceutical PreparationsIBA
01/2008
1Hemostatics (Antihemorrhagics)IBA
01/2008
1matrigelIBA
10/2007
1von Willebrand FactorIBA
04/2007
1P-SelectinIBA
04/2007
1Proteins (Proteins, Gene)FDA Link
07/2006

Therapy/Procedure

1Therapeutics
07/2006